
Metastatic Bladder Cancer — Rapid Case Review Issue 3
Oncology Today with Dr Neil Love
00:00
Re‑challenging immunotherapy after adjuvant IO
Milowsky contrasts urothelial and renal data, often favoring EV monotherapy rather than IO re‑challenge after adjuvant progression.
Play episode from 15:37
Transcript


